T-CELL LEUKEMIA/LYMPHOMA, ADULT
Clinical trials for T-CELL LEUKEMIA/LYMPHOMA, ADULT explained in plain language.
Never miss a new study
Get alerted when new T-CELL LEUKEMIA/LYMPHOMA, ADULT trials appear
Sign up with your email to follow new studies for T-CELL LEUKEMIA/LYMPHOMA, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Leukemia prevention trial targets High-Risk virus carriers
Prevention Recruiting nowThis study tests whether the drug mogamulizumab can prevent adult T-cell leukemia/lymphoma (ATL) in people infected with HTLV-1 who have early cell changes. About 134 participants will receive a limited course of the drug to reduce their viral load. The goal is to stop cancer bef…
Matched conditions: T-CELL LEUKEMIA/LYMPHOMA, ADULT
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Prevention
Last updated May 13, 2026 16:03 UTC
-
Scientists hunt for weakness in T-Cell cancers
Knowledge-focused Recruiting nowThis study looks for new ways to kill T-cell leukemia and lymphoma cells by changing their internal chemical balance. Researchers will test drug combinations in the lab using cells from 120 adult patients. The goal is to find treatments that can overcome drug resistance in these …
Matched conditions: T-CELL LEUKEMIA/LYMPHOMA, ADULT
Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Knowledge-focused
Last updated May 17, 2026 01:03 UTC